Position in ABCL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$70
-$34,062 QoQ
Shares Held
9
-99.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#149
of 150 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Derivatives in ABCL
reported options exposure · as of Jun 30, 2026CallValue
$363,455
CallShares
46,300
PutValue
$118,535
PutShares
15,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. ABCL ranks #124 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in ABCL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70 | 9 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $363,455 | 46,300 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $118,535 | 15,100 | Put | Sole | 2026-08-03 | |
| 2026-03-31 | $34,132 | 9,780 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $58,632 | 16,800 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $150,768 | 43,200 | Call | Sole | 2026-05-13 | |
| 2025-12-31 | $740,430 | 216,500 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $285,228 | 83,400 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $851,751 | 249,050 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,139,798 | 226,600 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $489,419 | 97,300 | Put | Sole | 2025-11-14 | |
| 2024-12-31 | $43,950 | 15,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $667,890 | 256,881 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $90,789 | 15,900 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $177,581 | 31,100 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $169,740 | 36,900 | Put | Sole | 2023-11-21 | |
| 2023-09-30 | $4,140 | 900 | Call | Sole | 2023-11-21 | |
| 2023-06-30 | $231,914 | 35,900 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $6,841 | 1,059 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $9,690 | 1,500 | Call | Sole | 2023-08-14 | |
| 2022-09-30 | $16,813 | 1,700 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $494,500 | 50,000 | Put | Sole | 2022-11-14 | |
| 2021-03-31 | $359,738 | 10,593 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||